AtaiBeckley
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
Atai Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
HQ Location
Munich (Germany)
Founded
2018
Employees
51 - 200
Total funding raised
$2.92B
Funding Status
Post-IPO Equity, $50.00M, July 1, 2025
atai is a clinical-stage biopharmaceutical company developing new mental health treatments that transform patient outcomes. Our research focuses on developing rapid-acting, effective and durable mental health treatments for large-scale impact.